Skip to content

Credit up to CHF 99.–

Finasteride

Finasteride is a prescription-only 5-alpha-reductase inhibitor that lowers the formation of dihydrotestosterone (DHT) and is well studied in hereditary hair loss in men. Whether it suits an individual is decided by a physician after weighing benefits, risks and personal circumstances.

Medical assessment. A few questions about your hair loss, then a Swiss doctor decides. No algorithm.

How does finasteride work?

In androgenetic alopecia, certain hair follicles are sensitive to dihydrotestosterone (DHT). Over the years, DHT contributes to these follicles shrinking and producing shorter, finer hairs. Finasteride inhibits type II 5-alpha-reductase, an enzyme involved in converting testosterone to DHT. [1]

Because hair grows in cycles, an effect does not show after days but only after months. The mechanism also explains why finasteride is discussed for hereditary hair loss and not for other forms such as telogen effluvium, where DHT plays no central role. You can read more about the condition itself on the page on androgenetic alopecia. Whether the ingredient is suitable in an individual case depends on factors such as age, other medication, plans to have children, medical history and tolerability.

Evidence

Key facts and figures

The figures below come from the studies listed at the end of this page and from the Swiss prescribing information. They describe study groups and do not predict the result for any one person.

  • In the two one-year authorisation trials, 1,553 men aged 18 to 41 received finasteride 1 mg or placebo. 1,215 of them were followed blinded for a second year. [1]
  • At baseline, the trials counted an average of 876 hairs in a circular area of 5.1 cm² at the back of the head. With finasteride, hair count was 107 hairs higher than with placebo after one year and 138 hairs higher after two years. With placebo, hair loss continued to progress. [1]
  • In the phase III trial of topical finasteride spray in 458 men, hair count in the target area rose by an average of 20.2 hairs after 24 weeks, compared with 6.7 hairs on placebo. Blood DHT fell by 34.5% with the spray and by 55.6% with tablets. [2]
  • A meta-analysis of 15 placebo-controlled trials with 4,495 participants found a 1.66-fold relative risk of sexual dysfunction with finasteride 1 mg. [3]
  • According to the Swiss prescribing information, drug-related sexual side effects occurred in the first 12 months in 3.8% of men on finasteride and 2.1% on placebo, and in 0.6% over the following four years. [4]
  • In Switzerland, 1 mg tablets are authorised for men with mild to moderate androgenetic alopecia, and a spray for men aged 18 to 41, both in supply category B. [4] [6] [7] [14]

What the studies show

Finasteride is one of the most thoroughly studied ingredients in male androgenetic alopecia. The large placebo-controlled trials measured not only whether new hair grew but also whether hair loss stopped. Both were assessed with hair counts in a marked scalp area and with standardised photographs. [1] The evidence is strongest for the oral form in men, and it is growing for topical forms. [2]

The time course matters. In the trials, the first differences from placebo became measurable after several months, and assessments took place after one and two years. [1] Judging the effect after a few weeks means judging too early. At the same time, study averages say nothing about an individual. Some men respond clearly, others barely at all. In areas where follicles have been inactive for a long time, expectations are more cautious. The effect only lasts as long as finasteride is used. After stopping, hair loss can increase again. [4]

Recent studies

Oral and topical forms

Finasteride can be taken orally or applied to the scalp. The oral form acts throughout the body, the topical form is applied locally. The phase III trial of a topical finasteride spray examined whether local application could affect hair count in a similar way while lowering blood DHT less. [2]

The difference is medically relevant, but it does not replace a physician’s decision. Some of the finasteride applied to the scalp also reaches the bloodstream, although in a much smaller amount. [2] The warnings in the prescribing information therefore apply to the topical form as well. [6] Your physician assesses, based on your information, which form is justifiable in your case. For absorption, tolerability and the evidence, see the comparison of topical and oral finasteride.

Authorisation and prescription status in Switzerland

In Switzerland, 1 mg finasteride tablets are authorised for men with mild to moderate androgenetic alopecia. [4] Besides the original product, generics with the same strength are available. [9] A finasteride spray is also authorised for men aged 18 to 41. [6] There is no authorisation for hair loss in women, children or adolescents.

All these products require a prescription and belong to supply category B. [7] [8] [14] This means they may only be dispensed against a medical prescription. Dispensing without a prescription, for example after advice in a drugstore, is not possible. The prescribing information for authorised products is publicly available on Swissmedicinfo and in the Swiss drug compendium. It is the authoritative source for indication, contraindications and warnings, and the basis for the information on this page. [4] [6]

Compounded preparations and what they mean for you

In addition to authorised ready-made medicines, a physician can prescribe an individual preparation that a pharmacy makes for one specific person. Swiss therapeutic products law calls this a magistral formula (formula magistralis). [10] Such preparations do not need their own authorisation from Swissmedic, because they are not marketed as a finished product but made against a specific prescription. [10]

For you, this has three practical consequences. First, an individual finasteride preparation also requires a prescription and a medical assessment. Second, it can differ from a ready-made product in concentration, base solution or combination. In that case there is no dedicated prescribing information, and the physician carries more responsibility for the choice. Third, the pharmacy is responsible for the quality of the preparation. A compounded preparation is not a better or worse medicine, it is a different route that may or may not suit a particular person.

Availability and costs

In Switzerland, finasteride is only available with a valid medical prescription, dispensed by a pharmacy or a self-dispensing medical practice. How long a prescription remains valid is regulated by each canton. Long-term treatment therefore needs a new medical assessment at regular intervals. [11]

In Switzerland, neither basic nor supplementary insurance covers treatment for hereditary hair loss. Under the Health Insurance Act, compulsory basic insurance only covers services that treat an illness and are effective, appropriate and economical, and finasteride is not on the list of pharmaceutical specialities for this use. [12] [13] Costs are made up of the medical consultation, the product or preparation and follow-up checks, which are billed separately or included depending on the provider. Because treatment runs for years, it is worth looking at the ongoing costs rather than just the first month. The guide What does hair loss treatment cost in Switzerland gives a neutral overview of the options and typical amounts.

Safety

Finasteride can cause side effects. These include sexual dysfunction, breast symptoms, skin reactions and mood symptoms. [3] [4] According to the Swiss prescribing information, sexual side effects were more common than with placebo in the first year of treatment and became rarer afterwards, the figures are listed above under «Key facts and figures». [4] Hypersensitivity reactions, testicular pain and breast symptoms are rare. How often depression, anxiety and suicidal thoughts occur is not known. [4] After market launch, it was also reported that sexual symptoms persist after stopping in some men. [4]

According to a communication agreed with Swissmedic in November 2025, treatment should be stopped and medical advice sought in the event of low mood, depression or suicidal thoughts. [5] Particular caution applies during pregnancy or possible contact with pregnant women. Liver disease, certain lab values such as PSA and other medication are also part of the medical assessment. [4]

Reference page and guides

This page is a reference. It describes what finasteride is, what the studies show, which risks are known and what its status is in Switzerland. It does not say whether finasteride is right for you, and it contains no dosing recommendation. The doses listed above reflect what is described in the authorisation and in the literature.

The guide finasteride prescription in Switzerland explains how a medical assessment and a possible prescription work in practice. The detailed evidence is in the guide finasteride efficacy and studies, the side effects in the guide to side effects. At orva, licensed Swiss physicians review your answers to a medical questionnaire and decide whether treatment is medically appropriate.

With orva, you can treat hair loss online in Switzerland. You start with a medical questionnaire. Licensed Swiss physicians review your information. If medically appropriate, the physician may issue a prescription.

When it may be used

  • Androgenetic alopecia when appropriate after physician review. In Switzerland, oral 1-mg tablets are approved for the treatment of men with mild to moderate androgenetic alopecia, and a finasteride spray for men aged 18 to 41. There is no indication in women or children; other uses are outside the authorization (off-label).

Drug Category

5-alpha-reductase inhibitor

Dosage

These entries are general examples from medicinal product information or physician-prescribed forms. Your actual use depends on the package leaflet or physician instructions.

  • Oral (tablet)

    Strength
    1 mg
    Frequency
    1x daily
    Prescription Required
    Yes
  • Oral (tablet, low dose; outside the authorization)

    Strength
    0.2 to 0.5 mg
    Frequency
    as directed by physician
    Prescription Required
    Yes
  • Topical (solution or spray; partly individually prepared)

    Strength
    0.005-0.25%
    Frequency
    as directed by physician
    Prescription Required
    Yes

Not suitable for

  • Existing or possible pregnancy (there is no indication in women)
  • Hypersensitivity to finasteride or any other component
  • Children and adolescents (not approved)

Side Effects

Common Side Effects

  • Decreased libido (1.8% with finasteride versus 1.3% with placebo)
  • Erectile dysfunction (1.3% versus 0.7% with placebo)

Uncommon Side Effects

  • Ejaculation disorders, decreased ejaculate volume

Rare Side Effects

  • Hypersensitivity reactions (rash, itching, hives, swelling of the face or throat)
  • Testicular pain, blood in semen, breast enlargement or breast pain
  • Very rare: male breast cancer
  • Frequency not known: depression, anxiety, suicidal thoughts
  • Frequency not known: sexual dysfunction persisting after discontinuation, male infertility or poor semen quality

Warnings & Precautions

  • Finasteride requires a prescription and should only be used after physician review.
  • People who are pregnant or may become pregnant should not handle broken tablets.
  • Finasteride can affect laboratory values such as PSA. Tell physicians if you use it.
  • Effects can only be assessed after several months of regular use.
  • Hair loss may increase again after discontinuation.
  • In case of depressed mood, depression or suicidal thoughts, treatment should be stopped and medical advice sought.
  • After marketing, sexual symptoms were reported to persist after stopping in some men. How often this happens is not known.

FAQ

Is finasteride prescription-only in Switzerland?

Yes. Finasteride belongs to supply category B and is only dispensed by pharmacies against a medical prescription. This applies to tablets, to the authorised spray and to compounded preparations. It is only prescribed when a physician considers it medically appropriate after reviewing your information.

When can I tell whether finasteride is working for me?

Hair changes take time. In the authorisation trials, assessments took place after one and two years. It usually takes several months of regular use to judge whether hair loss is stabilising or hair density is changing. Individual results can vary considerably.

Can finasteride be combined with minoxidil?

Finasteride and minoxidil work through different mechanisms and are often discussed together in the medical literature. Whether a combination makes sense is decided by the treating physician.

What side effects are possible?

Possible side effects include effects on libido, erection, ejaculation, breast tenderness, skin reactions or mood. According to the Swiss prescribing information, sexual side effects are more common than with placebo in the first year. Discuss any symptoms early with a healthcare professional.

Is topical finasteride the same as a tablet?

No. Topical and oral forms differ in how the active ingredient is absorbed. Which form is suitable depends on physician review, tolerability and personal context.

Does health insurance pay for finasteride for hair loss?

No. In Switzerland, neither basic nor supplementary insurance covers treatment for hereditary hair loss, and finasteride is not on the list of pharmaceutical specialities for this use.

Do I need a prescription for the treatment?

Prescription-only ingredients, for example DHT blockers, require a doctor's prescription. orva connects you with licensed Swiss doctors who review your answers online and issue a prescription if it is medically suitable. Some scalp solutions are available from Swiss pharmacies without a prescription.

Which active ingredients are available?

Options include a solution you apply to your scalp, a tablet, or both combined. Which active ingredients and which form suit you is decided by your doctor. Prescribed formulas are compounded for you by a licensed Swiss pharmacy.

Are the active ingredients scientifically studied?

Yes. The active ingredients for hereditary hair loss, meaning DHT blockers and ingredients that can lengthen the growth phase of the hair, have been studied in clinical trials. The evidence differs by ingredient and use. Individual results can vary, and which treatment is suitable is decided by your doctor.

General questions about orva

References

  1. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology, 1998.
  2. Piraccini BM, Blume-Peytavi U, Scarci F, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. Journal of the European Academy of Dermatology and Venereology, 2022.
  3. Lee S, Lee YB, Choe SJ, et al. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Acta Dermato-Venereologica, 2019.
  4. Organon GmbH. Propecia® 1 mg Filmtabletten, Fachinformation. Swissmedicinfo, 2026.
  5. Swissmedic. DHPC – Finasterid / Dutasterid: Neue Massnahmen zur Minimierung des Risikos für Suizidgedanken. Swissmedic, 2025.
  6. Bailleul (Suisse) SA. Fynzur Spray 2,275 mg/ml, Fachinformation. Swissmedicinfo, 2022.
  7. Swissmedic. Fragen und Antworten zu den Abgabekategorien (questions and answers on supply categories). Swissmedic, 2019.
  8. HCI Solutions AG. Propecia, Filmtabletten 1 mg. compendium.ch, 2026.
  9. Mepha Pharma AG. Finasterid-Mepha Procapil, Filmtabletten, Fachinformation (prescribing information). Swissmedicinfo, 2026.
  10. Swiss Confederation. Federal Act on Medicinal Products and Medical Devices (Therapeutic Products Act, TPA), Art. 9 para. 2 let. a (SR 812.21). Fedlex, 2025.
  11. SAMW and FMH. Rechtlicher Leitfaden, Ausstellen von Rezepten (legal guide, issuing prescriptions). SAMW, 2026.
  12. Swiss Confederation. Federal Act on Health Insurance (HIA), Art. 25, 32, 41 and 62 (SR 832.10). Fedlex, 2024.
  13. Federal Office of Public Health. Arzneimittel und Spezialitätenliste (medicines and list of pharmaceutical specialities). FOPH, 2026.
  14. HCI Solutions AG. FYNZUR Spray 2,275 mg/ml. compendium.ch, 2026.

Medical Disclaimer

This article is for informational purposes only and does not replace medical advice. Speak with a physician about the risks and benefits of treatment.

The information refers to the active ingredient in general and may not be accurate for all products containing this ingredient.

Editorial Standards

We strive for accurate and current information based on scientific sources.

Learn about our standards

Whether a treatment suits you is decided by a Swiss doctor.

Start with the medical questionnaire. A Swiss doctor reviews your information. The medical assessment costs CHF 99.–. If nothing is prescribed, you get the full amount back.

Five minutes today.A medical decision usually within 1 to 2 business days.